Company / Capital Expenditures
Apyx Medical Corp Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.1M
FY2025
5-year range
$581.0K / $1.1M
FY2021-FY2025
Trend
+54.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $286,000 in FY2018 to $1M in FY2020.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of -3.1%.
Improved from $1M to $1M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +3.3%
- 5-Year CAGR
- -3.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.1%, indicating a declining trend.
- In FY2025, capital expenditures increased 54.3% year-over-year.
- Peak capital expenditures was recorded in FY2020.
- Lowest capital expenditures in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | +54.3% |
| FY2024 | $722.0K | -28.5% |
| FY2023 | $1.0M | +0.0% |
| FY2022 | $1.0M | +73.8% |
| FY2021 | $581.0K | -55.3% |
| FY2020 | $1.3M | +108.5% |
| FY2019 | $624.0K | +118.2% |
| FY2018 | $286.0K | -32.1% |
| FY2017 | $421.0K | -33.2% |
| FY2016 | $630.0K | +7.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026